BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18452429)

  • 21. Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients.
    Lanska DJ
    Neurology; 2008 Jul; 71(2):150; author reply 150-1. PubMed ID: 18606972
    [No Abstract]   [Full Text] [Related]  

  • 22. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.
    Skogman BH; Croner S; Nordwall M; Eknefelt M; Ernerudh J; Forsberg P
    Pediatr Infect Dis J; 2008 Dec; 27(12):1089-94. PubMed ID: 19008771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
    Ledue TB; Collins MF; Young J; Schriefer ME
    Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe.
    Øymar K; Tveitnes D
    Scand J Infect Dis; 2009; 41(2):88-94. PubMed ID: 19065451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen biochips verify and extend the scope of antibody detection in Lyme borreliosis.
    Du W; Ma X; Nyman D; Povlsen K; Akguen N; Schneider EM
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):355-63. PubMed ID: 17888607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Borrelia burgdorferi IgG antibodies with a combination of IgG ELISA and VlsE C6 peptide ELISA.
    Jansson C; Carlsson SA; Granlund H; Wahlberg P; Nyman D
    Clin Microbiol Infect; 2005 Feb; 11(2):147-50. PubMed ID: 15679490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Children with multiple erythema migrans: are there any pre-treatment symptoms and/or signs suggestive for central nervous system involvement?
    Arnez M; Pleterski-Rigler D; Luznik-Bufon T; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):524-9. PubMed ID: 12422594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lyme neuroborreliosis in More and Romsdal].
    Eldøen G; Vik IS; Vik E; Midgard R
    Tidsskr Nor Laegeforen; 2001 Jun; 121(17):2008-11. PubMed ID: 11875896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
    Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
    Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective study.
    van Gorkom T; Kremer K; Voet W; Notermans DW; Vlaminckx BJM; Sankatsing SUC; Thijsen SFT
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2137-2146. PubMed ID: 28748396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PCR in lyme neuroborreliosis: a prospective study.
    Pícha D; Moravcová L; Zdárský E; Maresová V; Hulínský V
    Acta Neurol Scand; 2005 Nov; 112(5):287-92. PubMed ID: 16218909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.
    Pfister HW; Rupprecht TA
    Int J Med Microbiol; 2006 May; 296 Suppl 40():11-6. PubMed ID: 16524775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis.
    Ljøstad U; Skarpaas T; Mygland A
    Eur J Neurol; 2007 Aug; 14(8):873-6. PubMed ID: 17662007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid findings in patients with symptoms suggesting chronic Lyme borreliosis.
    Ogrinc K; Lotric-Furlan S; Maraspin V; Cimperman J; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):535-8. PubMed ID: 12422597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic relevance of the chemokine CXCL13 and anti-C6 peptide antibodies in patients with neuroborreliosis].
    Pícha D; Moravcová L; Smíšková D
    Epidemiol Mikrobiol Imunol; 2017; 66(2):80-85. PubMed ID: 28691831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lyme disease--a reason for sudden sensorineural hearing loss and vestibular neuronitis?].
    Walther LE; Hentschel H; Oehme A; Gudziol H; Beleites E
    Laryngorhinootologie; 2003 Apr; 82(4):249-57. PubMed ID: 12717599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical presentation of childhood neuroborreliosis; neurological examination may be normal.
    Broekhuijsen-van Henten DM; Braun KP; Wolfs TF
    Arch Dis Child; 2010 Nov; 95(11):910-4. PubMed ID: 20584849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antigens for serologic diagnosis of neuroborreliosis in children.
    Heikkilä T; Saxen H; Seppälä I; Lönnqvist T; Sillanpää H; Lahdenne P
    Pediatr Infect Dis J; 2005 Aug; 24(8):709-12. PubMed ID: 16094226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
    Wutte N; Archelos J; Crowe BA; Zenz W; Daghofer E; Fazekas F; Aberer E
    J Neurol Sci; 2014 Dec; 347(1-2):96-103. PubMed ID: 25288328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple sclerosis and Lyme borreliosis.
    Schmutzhard E
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):539-43. PubMed ID: 12422598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.